Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M55.0Revenue (TTM) $M4.8Net Margin (%)-26.8Altman Z-Score2.2
Enterprise Value $M52.4EPS (TTM) $--Operating Margin %-23.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-5.0Pre-tax Margin (%)-26.8Higher ROA y-yN
Price/Book11.310-y EBITDA Growth Rate %--Quick Ratio1.1Cash flow > EarningsY
Price/Sales12.25-y EBITDA Growth Rate %--Current Ratio1.1Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-178.6ROA % (ttm)-14.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-26.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M64.7ROIC % (ttm)-26.1Gross Margin Increase y-yY

Gurus Latest Trades with IGXT

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

IGXT is held by these investors:



IGXT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Boudreau BernardDirector 2016-11-30Sell25,000$0.7513.33view
Durham John EdwardVP Manufacturing 2016-10-07Buy3,000$0.7611.84view
Durham John EdwardVP Manufacturing 2016-09-21Buy10,000$0.832.41view
Godin AndreEVP & CFO 2016-09-14Buy20,000$0.7218.06view
Boudreau BernardDirector 2016-01-22Buy65,000$0.4973.47view
Bechard Robert J.VP Corporate Development 2016-01-22Buy10,000$0.570view
Godin AndreEVP + CFO 2016-01-20Buy20,000$0.4112.5view
Godin AndreEVP & CFO 2015-12-30Buy9,500$0.5263.46view
Godin AndreEVP + CFO 2015-12-23Buy15,350$0.5166.67view
Godin AndreEVP + CFO 2015-12-22Buy19,650$0.570view

Press Releases about IGXT :

Quarterly/Annual Reports about IGXT:

News about IGXT:

Articles On GuruFocus.com

More From Other Websites
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Feb 09 2017
IntelGenx and Tetra Bio-Pharma Announce the Signing of a Term Sheet for the Development and... Feb 09 2017
IntelGenx Presentation Now Available for On-Demand Viewing Feb 06 2017
IntelGenx Presentation Now Available for On-Demand Viewing Feb 06 2017
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present... Jan 30 2017
Life Sciences & Healthcare Investor Conference & Webinar: Nasdaq and OTCQX Companies Present... Jan 30 2017
/DISREGARD RELEASE: IntelGenx Technologies Corp./ Jan 30 2017
/DISREGARD RELEASE: IntelGenx Technologies Corp./ Jan 30 2017
IntelGenx to Webcast, Live, at VirtualInvestorConferences.com February 2 Jan 30 2017
IntelGenx to Webcast, Live, at VirtualInvestorConferences.com February 2 Jan 30 2017
IntelGenx Grants Stock Options Jan 19 2017
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Jan 04 2017
IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet Jan 04 2017
IntelGenx Announces Definitive Agreement with Chemo Group for a Generic CNS Tablet Jan 04 2017
IntelGenx Announces Development and Commercialization Agreement with Endo Ventures Dec 27 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Dec 27 2016
IntelGenx Announces Development and Commercialization Agreement with Endo Ventures Dec 27 2016
INTELGENX TECHNOLOGIES CORP. Files SEC form 8-K, Other Events Dec 14 2016
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT®... Dec 14 2016
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT®... Dec 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)